Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

135

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

Tags:

Previous Article

Broadly neutralizing antibodies against emerging delta-coronaviruses

Immunotherapy for glioblastoma and its microenvironment

Related Posts

Intravenous administration of blood–brain barrier-crossing conjugates facilitate biomacromolecule transport into central nervous system

Intravenous administration of blood–brain barrier-cross...

110

Platelets: tailoring metastasis treatment

Platelets: tailoring metastasis treatment

87

Divergent sensory pathways of sneezing and coughing

Divergent sensory pathways of sneezing and coughing

104